Comment on

• Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures.

  van den Bogaard VA, Ta BD, van der Schaaf A, Bouma AB, Middag AM, Bantema-Joppe EJ, van Dijk LV, van Dijk-Peters FB, Marteijn LA, de Bock GH, Burgerhof JG, Gietema JA, Langendijk JA, Maduro JH, Crijns AP. van den Bogaard VA, et al. J Clin Oncol. 2017 Apr 10;35(11):1171-1178. doi: 10.1200/JCO.2016.69.8480. Epub 2017 Jan 17. J Clin Oncol. 2017. PMID: 28095159 Free PMC article.
• Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

  Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, Dodwell D, Ewertz M, Gray R, Jagsi R, Pierce L, Pritchard KI, Swain S, Wang Z, Wang Y, Whelan T, Peto R, McGale P; Early Breast Cancer Trialists’ Collaborative Group. Taylor C, et al. J Clin Oncol. 2017 May 20;35(15):1641-1649. doi: 10.1200/JCO.2016.72.0722. Epub 2017 Mar 20. J Clin Oncol. 2017. PMID: 28319436 Free PMC article.
• Self-reported long-term cardiac morbidity in breast cancer patients: a retrospective cohort study in Germany (PASSOS Heart Study).

  Wollschläger D, Merzenich H, Schwentner L, Janni W, Wiegel T, Bartkowiak D, Wöckel A, Schmidt M, Schmidberger H, Blettner M. Wollschläger D, et al. Breast Cancer Res Treat. 2017 Jun;163(3):595-604. doi: 10.1007/s10549-017-4215-7. Epub 2017 Mar 28. Breast Cancer Res Treat. 2017. PMID: 28353062
• No Acute Changes in LVEF Observed With Concurrent Trastuzumab and Breast Radiation With Low Heart Doses.

  Bian SX, Korah MP, Whitaker TR, Ji L, Groshen S, Chung E. Bian SX, et al. Clin Breast Cancer. 2017 Nov;17(7):510-515. doi: 10.1016/j.clbc.2017.03.011. Epub 2017 Mar 23. Clin Breast Cancer. 2017. PMID: 28412326 Free PMC article.